Post-mastectomy radiotherapy benefits subgroups of breast cancer patients with T1-2 tumor and 1–3 axillary lymph node(s) metastasis
Background. To determine the role of postmastectomy radiotherapy (PMRT) in breast cancer patients with T1-2 and N1 disease.
Main Authors: | Su Yu-Li, Li Shan-Hsuan, Chen Yen-Yang, Chen Hui-Chun, Tang Yen, Huang Cheng-Hua, Chou Fong-Fu, Wu Shih-Chung, Rau Kun-Ming |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2014-09-01
|
Series: | Radiology and Oncology |
Subjects: | |
Online Access: | https://doi.org/10.2478/raon-2013-0085 |
Similar Items
-
Effects of postmastectomy radiotherapy on prognosis in different tumor stages of breast cancer patients with positive axillary lymph nodes
by: Miao-Miao Jia, et al.
Published: (2014-06-01) -
Is postmastectomy radiotherapy really needed in breast cancer patients with many positive axillary lymph nodes?
by: Marinko Tanja, et al.
Published: (2018-03-01) -
The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype
by: Jinli Wei, et al.
Published: (2020-06-01) -
A Prognostic Risk Stratification Model to Identify Potential Population Benefiting From Postmastectomy Radiotherapy in T1–2 Breast Cancer With 1–3 Positive Axillary Lymph Nodes
by: Niuniu Hou, et al.
Published: (2021-04-01) -
Assessment of lymphovascular invasion in gastric carcinoma; do they always indicate lymph node metastasis?
by: Kricha Pande, et al.
Published: (2018-04-01)